Year None2022202120202019201820172016 Date Latest Press Release May 10, 2016 Eiger Announces First Patient Dosed in Phase 2 Multiple Ascending Dose Study of Subcutaneous Exendin (9-39) in Patients with Hypoglycemia Post-Gastric Bypass Surgery May 3, 2016 Eiger Bio Strengthens Senior Management Team with Announcement of Debra Odink, PhD as Senior Vice President of Technical Operations April 20, 2016 Eiger BioPharmaceuticals Announces License of Worldwide Rights to Pegylated Interferon Lambda-1a from Bristol-Myers Squibb April 4, 2016 Eiger BioPharmaceuticals Strengthens Board of Directors with Addition of Industry Veteran Charles J. "Chuck" Bramlage March 30, 2016 Eiger BioPharmaceuticals Announces Abstracts and Presentations of Lonafarnib Data in Hepatitis Delta at the European Association for the Study of the Liver (EASL) Meeting March 28, 2016 Eiger BioPharmaceuticals Granted Orphan Medicinal Product Designation for Ubenimex in Pulmonary Arterial Hypertension by European Medicines Agency March 22, 2016 Eiger BioPharmaceuticals Closes Merger With Celladon Pagination First page « first Previous page ‹ previous … Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Current page 23
